|
FDA Extends PDUFA Date for Impax Parkinson’s Drug by Three Months
The FDA wants more time to review Impax Laboratories’ Parkinson’s treatment Rytary and is pushing back its decision date to Jan. 21, 2013.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives